Edition:
United Kingdom

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

6.00USD
13 Dec 2017
Change (% chg)

$0.21 (+3.63%)
Prev Close
$5.79
Open
$5.80
Day's High
$6.05
Day's Low
$5.80
Volume
40,977
Avg. Vol
84,635
52-wk High
$6.65
52-wk Low
$1.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 3.93 -0.159
Jun '17 1.85 -0.232
Mar '17 1.34 -0.186
FY 2016 Dec '16 2.73 -0.152
Sep '16 0.79 -0.144
Jun '16 1.07 -0.144
Mar '16 1.25 -0.104
FY 2015 Dec '15 2.14 -0.073
Sep '15 0.41 -0.101
Jun '15 0.16 -0.120
Mar '15 0.22 -0.126
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 3.79 4.20 3.18 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-17 3 10.91 11.32 10.30 5.73
Year Ending Dec-18 3 12.56 15.00 10.50 2.10
Earnings (per share)
Quarter Ending Dec-17 3 -0.13 -0.12 -0.15 --
Quarter Ending Mar-18 1 -0.14 -0.14 -0.14 --
Year Ending Dec-17 3 -0.71 -0.70 -0.73 -0.61
Year Ending Dec-18 3 -0.64 -0.51 -0.74 -0.63
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 41.16 100.67 5.40
Price to Book (MRQ) 29.26 13.50 5.38
Price to Tangible Book (MRQ) 29.57 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 50.96 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 72.70 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago 37.63 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -61.36 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -69.16 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 2.87 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -92.13 -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -417.27 -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -424.61 -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -445.15 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -459.70 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 136,884 25,314,503 864,673,362
Net Income/Employee (TTM) -629,254 3,332,048 101,717,513
Receivable Turnover (TTM) -- 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.09 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.46 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -55.96 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -132.26 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 98.87 -22.30 --
EPS (TTM) % -33.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Pieris Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 50.66%
# of Holders: 93
Total Shares Held: 22,690,872
3 Mo. Net Change: 246,143
# New Positions: 26
# Closed Positions: 3
# Increased Positions: 52
# Reduced Positions: 20
# Net Buyers: 32
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.